Floatz logo

306 assets in B-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing B-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
DS3790a
B-Cell Non-Hodgkin Lymphoma
Daiichi SankyoP1/2CC (45)
Anti-Cd19 Car T-Cells
B-Cell Non-Hodgkin Lymphoma
Vinmec Research Institute of Stem Cell and Gene TechnologyP1CC (44)
Azacitidine
B-Cell Non-Hodgkin Lymphoma
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (44)
Nogapendekin Alfa Inbakicept
B-Cell Non-Hodgkin Lymphoma
ImmunityBio, Inc.P2CC (44)
Pclx 001
B-Cell Non-Hodgkin Lymphoma
Pacylex PharmaceuticalsP1CC (44)
Aleta-001
B-Cell Non-Hodgkin Lymphoma
Cancer Research UKP1/2CC (43)
Anti-Cd19 Autologous Car-T Cell Infusion
B-Cell Non-Hodgkin Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaP1/2CC (43)
Anti-Cd19 Il10/Il15 Car-Nk
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
Anti-Cd19 Ucar-Nk Cells
B-Cell Non-Hodgkin Lymphoma
Kunming Hope of Health HospitalP1/2CC (43)
ata3219
B-Cell Non-Hodgkin Lymphoma
Atara BiotherapeuticsP1CC (43)
Autologous Anti-Cd19 Car-Expressing T-Lymphocytes Ic19/1563
B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Obtained By Apheresis Transduced Ex Vivo With A Non-Replicating, Self-Inactivating (Sin) Lentiviral Vector, Encoding A Chimeric Antigen Receptor (Car) Consisting Of An Anti-Cd19 Specific Scfv, A Cd8.Alpha. Stalk, Transmembrane Domain And Anchor, A 41Bb Endodomain And A Cd3 Zeta Endodomain, Under The Control Of A Human Pgk1 Promoter And A Modified Woodchuck Post Transcriptional Response Element. The Vector Genome Also Contains A 5' Terminal Cmv Enhancer/Promoter, A .Psi. Packaging Signal, A Rev Response Element (Rre) And A Central Polypurine Tract (Cppt)
B-Cell Non-Hodgkin Lymphoma
Autolus LimitedP1CC (43)
Baff Car-T
B-Cell Non-Hodgkin Lymphoma
Luminary TherapeuticsP1CC (43)
Baffr-Car T Cells
B-Cell Non-Hodgkin Lymphoma
PeproMene Bio, Inc.P1CC (43)
Belinostat
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (43)
Bgb-16673
B-Cell Non-Hodgkin Lymphoma
BeOne MedicinesP1/2CC (43)
bn301
B-Cell Non-Hodgkin Lymphoma
BioNova Pharmaceuticals (Shanghai) LTD.P1/2CC (43)
CAR20(NAP)-T
B-Cell Non-Hodgkin Lymphoma
Uppsala UniversityP1/2CC (43)
Car.70/Il15-Transduced Cb-Nk Cells
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (43)
Cart-45 Cells
B-Cell Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (43)
CD19.CAR-aNKT cells
B-Cell Non-Hodgkin Lymphoma
Baylor College of MedicineP1CC (43)
CD19-CAR-DNT cells
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
cd19-car novel oncolytic vaccinia virus
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
cd19-cd34 car transduced t cells
B-Cell Non-Hodgkin Lymphoma
Loyola UniversityP1CC (43)
cd45be-hspc
B-Cell Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (43)
Cedazuridine
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (43)
ctx112
B-Cell Non-Hodgkin Lymphoma
CRISPR Therapeutics AGP1/2CC (43)
cy-219 car-t
B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1CC (43)
ibr900 cell
B-Cell Non-Hodgkin Lymphoma
Imbioray (Hangzhou) Biomedicine Co., Ltd.P1CC (43)
int2104
B-Cell Non-Hodgkin Lymphoma
Kite, A Gilead CompanyP1CC (43)
ism8207
B-Cell Non-Hodgkin Lymphoma
InSilico Medicine Hong Kong LimitedP1CC (43)
Jnj-90009530
B-Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1CC (43)
js203 for
B-Cell Non-Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd.P1CC (43)
jv-213
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1CC (43)
kq-2002 car-t cells 〈cd19/cd22 car t-cells〉
B-Cell Non-Hodgkin Lymphoma
Rong TaoP1CC (43)
l218car19
B-Cell Non-Hodgkin Lymphoma
Henan Cancer HospitalP1CC (43)
Lcar-Aio Cells
B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1CC (43)
Lucar-20Sp Cells
B-Cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & InstituteP1CC (43)
Lucar-G39P Cells Product
B-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
ly007
B-Cell Non-Hodgkin Lymphoma
Ruijin HospitalP1CC (43)
Mb-Cart19.1
B-Cell Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbHP1CC (43)
mk-1045
B-Cell Non-Hodgkin Lymphoma
MSD R&D (China) Co., Ltd.P1CC (43)
Nemtabrutinib
B-Cell Non-Hodgkin Lymphoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)P1/2CC (43)
Personalized Neoantigen Tumor Vaccine
B-Cell Non-Hodgkin Lymphoma
Ruijin HospitalP1CC (43)
pit565
B-Cell Non-Hodgkin Lymphoma
Novartis PharmaceuticalsP1CC (43)
Pomalidomide
B-Cell Non-Hodgkin Lymphoma
University of Michigan Rogel Cancer CenterP1CC (43)
psb202
B-Cell Non-Hodgkin Lymphoma
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)P1CC (43)
qh103 cell
B-Cell Non-Hodgkin Lymphoma
The Second Affiliated Hospital of Fujian Medical UniversityP1CC (43)
Recombinant Cd20 Monoclonal Antibody-Mmae Conjugte For
B-Cell Non-Hodgkin Lymphoma
Zhejiang Teruisi Pharmaceutical Inc.P1CC (43)
rgv004
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
Showing 151 to 200 of 306 assets
PreviousPage 4 of 7Next